Shalby Valuation Multiples

Discover revenue and EBITDA valuation multiples for Shalby and similar public comparables like Goodwill Pharma, Suraksha Diagnostics, Athens Medical Centre, Monash IVF Group and more.

Shalby Overview

About Shalby

Shalby Ltd operates a chain of multispecialty hospitals. It is engaged in setting up and managing hospitals and medical diagnostic services. The hospitals offer healthcare services to patients in various areas of specialization such as Cardiology, Emergency Medicine, Gastroenterology Surgery, Arthroscopy Sports Injury, Infectious Diseases, Oncology, and others. The activities are mainly conducted only in India. Revenue mainly comprises fees charged for inpatient and outpatient hospital services. Services include charges for accommodation, medical professional services, equipment, radiology, laboratory, and pharmaceutical goods used in treatments given to Patients.


Founded

2004

HQ

India

Employees

2.8K

Website

shalby.org

Financials (LTM)

Revenue: $122M
EBITDA: $15M

EV

$229M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Shalby Financials

Shalby reported last 12-month revenue of $122M and EBITDA of $15M.

In the same LTM period, Shalby generated $15M in EBITDA and $4M in net income.


Shalby P&L

In the most recent fiscal year, Shalby reported revenue of $120M and EBITDA of $18M.

Shalby is profitable as of last fiscal year, with gross margin of 41%, EBITDA margin of 15%, and net margin of 3%.

See analyst estimates for Shalby
LTMLast FY202320242025202620272028
Revenue$122M$120M$94M$109M$118M
Gross Profit-$49M$43M$46M$48M
Gross Margin-41%46%42%41%
EBITDA$15M$18M$19M$17M$17M
EBITDA Margin12%15%21%16%15%
EBIT Margin6%6%13%9%7%
Net Profit$4M$4M$8M$3M$3M
Net Margin3%3%9%2%3%
Net Debt-$54M---

Financial data powered by Morningstar, Inc.

Shalby Stock Performance

Shalby has current market cap of $176M, and enterprise value of $229M.


Shalby's stock price is $1.64.

Shalby has an EPS (earnings per share) of $0.04.

See more trading valuation data for Shalby
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$229M$176M-0.2%---$0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Shalby Valuation Multiples

Shalby trades at 1.9x EV/Revenue multiple, and 15.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Shalby

Shalby Financial Valuation Multiples

As of August 14, 2026, Shalby has market cap of $176M and EV of $229M.

Shalby has a P/E ratio of 41.7x.

LTMLast FY202320242025202620272028
EV/Revenue1.9x1.9x2.4x2.1x1.9x
EV/EBITDA15.1x12.9x11.7x13.1x13.1x
EV/EBIT29.8x30.0x18.2x24.1x29.4x
EV/Gross Profit-4.7x5.3x5.0x4.7x
P/E41.7x44.9x21.0x65.4x56.8x
EV/FCF(44.9x)(14.6x)n/m(34.2x)(16.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Shalby Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Shalby Margins & Growth Rates

Shalby grew revenue by 6% but EBITDA decreased by 13% in the last fiscal year.

In the most recent fiscal year, Shalby reported gross margin of 41%, EBITDA margin of 15%, and net margin of 3%.

See estimated margins and future growth rates for Shalby

Shalby Margins

Last FY202420252026202720282029
Gross Margin41%42%41%39%
EBITDA Margin15%16%15%13%
EBIT Margin6%9%7%6%
Net Margin3%2%3%4%
FCF Margin(13%)(6%)(12%)4%

Shalby Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth6%16%8%6%
Gross Profit Growth-7%5%1%
EBITDA Growth(13%)(10%)0%(8%)
EBIT Growth2%(24%)(18%)(0%)
Net Profit Growth21%(68%)15%47%
FCF Growth(176%)667%105%(136%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Shalby Operational KPIs

Shalby's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.0M for the same period.

Shalby's Rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Shalby's Rule of X is 28% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Shalby
LTMLast FY202320242025202620272028
Rule of 4021%19%---
Bessemer Rule of X33%28%---
Revenue per Employee-$0.0M---
Opex per Employee-$0.0M---
S&M Expenses to Revenue--3%2%2%
G&A Expenses to Revenue--1%1%0%
Opex to Revenue-34%32%34%34%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Goodwill Pharma2.8x-10.4x-
Suraksha Diagnostics5.4x5.1x17.1x16.2x
Athens Medical Centre1.1x-10.5x-
Monash IVF Group1.7x1.7x7.3x8.0x
Limes Schlosskliniken3.4x2.8x13.2x10.3x
Clinica Las Condes2.7x-(5.9x)-
Oncoclínicas0.8x0.8x(2.0x)6.0x
Centrum Medyczne ENEL-MED1.0x-7.9x-

This data is available for Pro users. Sign up to see all Shalby competitors and their valuation data.

Start Free Trial

Shalby VC Funding History

Before going public, Shalby raised $23M in total equity funding, across 1 round.

Last private valuation of Shalby was $236M, after raising $23M in December 2017.


Shalby Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Dec-17Undisclosed stage-$23M$236MShalby Limited is an Ahmedabad-based multi-specialty hospital chain that completed its IPO in December 2017. The company raised Rs 504 crore at the upper price band of Rs 248 per share through a fresh issue of Rs 480 crore in equity shares, with proceeds directed toward repayment of borrowings and purchase of medical equipment for existing and upcoming hospitals. At the IPO price, Shalby achieved a post-money market capitalization of Rs 2,207.18 crore as of March 31, 2018. For FY2017-18 (year ended March 31, 2018), Shalby reported revenue of Rs 3,923 million with year-on-year growth of 19 percent and EBITDA of Rs 7,383 million, also growing 19 percent year-on-year. The company demonstrated a 16-year revenue CAGR of 31 percent and achieved a 24 percent year-on-year revenue growth rate, positioning itself among the highest growth rates in the Indian healthcare industry. Established in 1994 by Dr. Vikram I. Shah, Shalby had grown into a significant tertiary and quaternary healthcare service provider, with promoters retaining 79.41 percent of equity capital immediately following the IPO.

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Shalby

When was Shalby founded?Shalby was founded in 2004.
Where is Shalby headquartered?Shalby is headquartered in India.
How many employees does Shalby have?As of today, Shalby has over 2K employees.
Is Shalby publicly listed?Yes, Shalby is a public company listed on National Stock Exchange of India.
What is the stock symbol of Shalby?Shalby trades under SHALBY ticker.
When did Shalby go public?Shalby went public in 2017.
Who are competitors of Shalby?Shalby main competitors include Goodwill Pharma, Suraksha Diagnostics, Athens Medical Centre, Monash IVF Group, Limes Schlosskliniken, Clinica Las Condes, Oncoclínicas, Centrum Medyczne ENEL-MED, Atrys Health, Fonar.
What is the current market cap of Shalby?Shalby's current market cap is $176M.
What is the current revenue of Shalby?Shalby's last 12 months revenue is $122M.
What is the current revenue growth of Shalby?Shalby revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Shalby?Current revenue multiple of Shalby is 1.9x.
What is the current EBITDA of Shalby?Shalby's last 12 months EBITDA is $15M.
What is Shalby's EBITDA margin?Shalby's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Shalby?Current EBITDA multiple of Shalby is 15.1x.
What is the current FCF of Shalby?Shalby's last 12 months FCF is ($5M).
What is Shalby's FCF margin?Shalby's last 12 months FCF margin is (4%).
What is the current EV/FCF multiple of Shalby?Current FCF multiple of Shalby is (44.9x).
How many companies Shalby has acquired to date?Shalby hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Shalby has invested to date?Shalby hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Shalby

Lists including Shalby

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial